Oxybutynin CL ER 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJSPD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,838
Award facts
- Contract value 100% obligated
- $4,838.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,838.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Oxybutynin Chloride Extended Release 10 mg tablets in quantities of 90 units. This delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, is structured as a firm fixed-price contract with no set-aside designation. The award represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts for diverse pharmaceutical products ranging from prescription medications to biologics and medical consumables. The company's extensive portfolio of federal contract awards demonstrates its capability to support Department of Defense healthcare operations globally. This particular delivery order for Oxybutynin chloride tablets exemplifies the routine procurement of essential medications through the SPE2DB program to maintain adequate pharmaceutical inventory across military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FJSPD?
SPE2DB25FJSPD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJSPD worth?
The government has obligated $4,838 on SPE2DB25FJSPD.
Is contract SPE2DB25FJSPD an order under another contract?
Yes. SPE2DB25FJSPD is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB25FJSPD competed?
The extent of competition for SPE2DB25FJSPD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award